Activist investor Elliott threatens Southwest Airlines proxy fight for leadership changes
Adds Southwest's comments in paragraph 5
By Rajesh Kumar Singh and Shivansh Tiwary
July 8 (Reuters) -Activist investor Elliott Investment Management on Monday warned of a proxy fight to push for leadership changes at U.S. budget carrier Southwest Airlines LUV.N.
In a letter to Southwest's board, Elliott said while it is open to collaboration, it plans to "move expeditiously to give shareholders a direct say on the necessary leadership changes."
The investment management firm, known for pushing changes to boost shareholder returns, has called for a reconstitution of Southwest's board with "new, truly independent" directors possessing expertise in airlines, customer experience and technology.
Ithas also called for a leadership change citing Southwest's disappointing financial results.
In a statement, Southwest said it remains open to constructive conversations with Elliott, including evaluating additional "strong and independent" director candidates. The airline, however, added the investment firm has focused on personal attacks on its leadership and board, conditioning any serious discussions on an immediate CEO change.
In its letter, Elliott said the airline's performance is "unacceptable" and a leadership change is required to return it to its once-leading position in the industry.
"Shareholders simply do not believe this board and management team are capable of devising and executing a bold new plan to turn around Southwest," it said.
Elliott currently owns an 11% stake in the company, making it one of the largest investors.
Last week, Southwest said the activist investor had made filings with antitrust authorities that would allow it to acquire an even larger voting power as early as July 11. It prompted the company to adopt a "poison pill", used by corporate boards to thwart hostile takeover bids, to deter Elliott from raising its stake.
Elliott said it is not seeking control of Southwest, but added the airline's board has put its own "self-interest ahead of the company's" by adopting the "poison pill."
It also criticized the appointment of aviation industry veteran Rakesh Gangwal to Southwest's board, calling it an attempt on the part of the board to "entrench itself and the current management team."
"These actions...demonstrate how profoundly out of touch Southwest's board has become with shareholder sentiment and with the reality of the situation," Elliott said in its letter.
Gangwal - who co-founded InterGlobe Aviation INGL.NS, the operator of India's largest airline IndiGo - has also served on the boards of US Airways Group, CarMax KMX.N and Office Depot, among others.
"Rakesh's expertise in travel technology will be valuable as we continue to make investments that support our operations and strategic initiatives," said Gary Kelly, executive chairman of Southwest's board.
Reporting by Rajesh Kumar Singh in Chicago and Shivansh Tiwary in Bengaluru; Editing by Shilpi Majumdar, Anil D'Silva and Josie Kao
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
